The solid progress of nanomedicine

João Pedro Martins, José das Neves, María de la Fuente, Christian Celia, Helena Florindo, Nazende Günday-Türeli, Amirali Popat, José Luis Santos, Flávia Sousa, Ruth Schmid, Joy Wolfram, Bruno Sarmento, Hélder A. Santos

Research output: Contribution to journalComment/debateScientificpeer-review

Abstract

This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion.
Original languageEnglish
JournalDrug Delivery and Translational Research
Volume10
Issue number3
Pages (from-to)726–729
Number of pages4
ISSN2190-393X
DOIs
Publication statusPublished - Jun 2020
MoE publication typeA1 Journal article-refereed

Fields of Science

  • CANCER
  • CHEMOTHERAPY
  • Cancer therapy
  • Clinical translation
  • Nanomedicine
  • Nanotechnology
  • PACLITAXEL
  • Reproducibility
  • THERAPY
  • TUMOR
  • 3122 Cancers
  • 221 Nano-technology
  • 317 Pharmacy

Cite this

Martins, J. P., das Neves, J., de la Fuente, M., Celia, C., Florindo, H., Günday-Türeli, N., ... Santos, H. A. (2020). The solid progress of nanomedicine. Drug Delivery and Translational Research, 10(3), 726–729. https://doi.org/10.1007/s13346-020-00743-2